1.
Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a...
by Fitzgerald, Kevin, Dr
The Lancet (British edition), 2014, Vol.383 (9911), p.60-68
2.
Genetic and Metabolic Determinants of Plasma PCSK9 Levels
by Lakoski, Susan G
The journal of clinical endocrinology and metabolism, 2009, Vol.94 (7), p.2537-2543
3.
Heterozygous Reelin Mutations Cause Autosomal-Dominant Lateral Temporal Epilepsy
by Dazzo, Emanuela
American journal of human genetics, 2015, Vol.96 (6), p.992-1000
4.
Molecular Characterization of Loss-of-Function Mutations in PCSK9 and Identification of a Compound Heterozygote
by Zhao, Zhenze
American journal of human genetics, 2006, Vol.79 (3), p.514-523
5.
Targeting PCSK9 for hypercholesterolemia
by Norata, Giuseppe Danilo
Annual review of pharmacology and toxicology, 2014, Vol.54 (1), p.273-293
6.
The loss-of-function PCSK9 p.R46L genetic variant does not alter glucose homeostasis
by Bonnefond, Amélie
Diabetologia, 2015, Vol.58 (9), p.2051-2055
7.
Removal of Plasma Mature and Furin-Cleaved Proprotein Convertase Subtilisin/Kexin 9 by Low-Density Lipoprotein-Apheresis in Familial Hypercholesterolemia: Development and Applicati...
by Hori, Mika
The journal of clinical endocrinology and metabolism, 2015, Vol.100 (1), p.E41-E49
8.
Varying Allergen Composition and Content Affects the in vivo Allergenic Activity of Commercial Dermatophagoides pteronyssinus Extracts
by Casset, Anne
International archives of allergy and immunology, 2012, Vol.159 (3), p.253-262
9.
Effect of Leptin Replacement on PCSK9 in ob/ob Mice and Female Lipodystrophic Patients
by Levenson, Amy E
Endocrinology (Philadelphia), 2016, Vol.157 (4), p.1421-1429
10.
Effects of Niacin , Statin , and Fenofibrate on Circulating Proprotein Convertase Subtilisin/Kexin Type 9 Levels in Patients With Dyslipidemia
by Khera, Amit V., MD
The American journal of cardiology, 2015, Vol.115 (2), p.178-182
11.
Albuminuria is associated with an increased prostasin in urine while aldosterone has no direct effect on urine and kidney tissue abundance of prostasin
by Oxlund, Christina
Pflügers Archiv, 2017, Vol.469 (5-6), p.655-667
12.
Tryptase genetics and anaphylaxis
by Caughey, George H
Journal of allergy and clinical immunology, 2006, Vol.117 (6), p.1411-1414
13.
Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer’s disease patients
by Bram, Jessyka Maria de França
European archives of psychiatry and clinical neuroscience, 2018, Vol.269 (8), p.963-972
14.
Plasma PCSK9 Is a Late Biomarker of Severity in Patients With Severe Trauma Injury
by Le Bras, Maëlle
The journal of clinical endocrinology and metabolism, 2013, Vol.98 (4), p.E732-E736
15.
Association Between High Serum Soluble Corin and Hypertension: A Cross-Sectional Study in a General Population of China
by Peng, Hao
American journal of hypertension, 2015, Vol.28 (9), p.1141-1149
16.
Validation of HAV biomarker 2A for differential diagnostic of hepatitis A infected and vaccinated individuals using multiplex serology
by Bohm, Katrin
Vaccine, 2017, Vol.35 (43), p.5883-5889
17.
Expression analysis of beta-secretase 1 (BACE1) and its naturally occurring antisense (BACE1-AS) in blood of epileptic patients
by Mazdeh, Mehrdokht
Neurological sciences, 2018, Vol.39 (9), p.1565-1569
18.
Elevated Circulating PCSK-9 Concentration in Renal Failure Patients is Corrected by Renal Replacement Therapy
by Konarzewski, Marcin
American journal of nephrology, 2014, Vol.40 (2), p.157-163
19.
Indices of Cholesterol Metabolism and Relative Responsiveness to Ezetimibe and Simvastatin
by Lakoski, Susan G
The journal of clinical endocrinology and metabolism, 2010, Vol.95 (2), p.800-809
20.
Pregnancy-associated glycoprotein (PAG) concentration in plasma and milk samples for early pregnancy diagnosis in Lacaune dairy sheep
by El Amiri, B
Research in veterinary science, 2015, Vol.99, p.30-36
